\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ revealed\\ decreased\\ breath\\ sound\\,\\ poor\\ ventilation\\,\\ and\\ expiratory\\ wheezing\\.\\ \\ laboratory\\ assessment\\ \\(cbc\\,\\ chem\\)\\ were\\ unrevealing\\.\\ \\ prior\\ labs\\ revealed\\ no\\ hormonal\\ abnormalities\\.\ \(0\)\
\-\ progression\\ of\\ imaging\\ findings\\ is\\ compatible\\ with\\ worsening\\ metastatic\\ disease\\ from\\ paraganglioma\\.\\ \\ the\\ original\\ site\\ of\\ tumor\\ \\(head\\+neck\\,\\ adrenal\\,\\ extra\\-adrenal\\)\\ has\\ not\\ been\\ confirmed\\,\\ but\\ no\\ adrenal\\ lesion\\ was\\ discovered\\.\\ \\ a\\ laryngeal\\ lesion\\ was\\ found\\ recently\\,\\ but\\ this\\ may\\ also\\ be\\ metastatic\\.\\ \\ the\\ chest\\ lesions\\ have\\ not\\ been\\ biopsied\\ due\\ to\\ concern\\ for\\ bleeding\\ \\-\\-\\ but\\ they\\ are\\ presumed\\ to\\ be\\ metastatic\\ in\\ nature\\.\\ \\ \\ the\\ patient\\ has\\ had\\ radiotherapy\\ to\\ the\\ spine\\ \\(which\\ has\\ partially\\ improved\\ multilevel\\ degenerative\\ disc\\ abnormalities\\)\\.\\ \\ chest\\ radiation\\ is\\ being\\ considered\\.\ \(0\)\
\-\ cxr\\ reveals\\ multiple\\ pulmonary\\ nodules\\.\\ \\ there\\ is\\ also\\ a\\ large\\ middle\\ mediastinal\\ mass\\ encasing\\ the\\ trachea\\.\\ \\ chest\\ ct\\ reveals\\ that\\ the\\ mass\\ is\\ hypervascular\\ in\\ its\\ periphery\\,\\ with\\ the\\ center\\ of\\ the\\ mass\\ being\\ hypovascular\\ and\\ potentially\\ partially\\ calcified\\.\ \(0\)\
\-\ metastatic\\ paraganglioma\ \(1\)\
\-\ \\â\\€\\¢\\ vascular\\ mass\\ \\-\\ hemangioma\\,\\ angiosarcoma\\,\\ partially\\ thrombosed\\ aneurysm\ \(0\)\
\-\ \\â\\€\\¢\\ neoplasms\\ \\-\\ metastatic\\ hypervascular\\ tumors\\ \\(thyroid\\,\\ hcc\\,\\ melanoma\\,\\ breast\\,\\ rcc\\,\\ neuroendocrine\\ tumors\\,\\ sarcomas\\)\ \(0\)\
\-\ \\â\\€\\¢\\ svc\\ syndrome\\ with\\ vascular\\ collaterals\\ simulating\\ a\\ hypervascular\\ lesion\\,\\ making\\ lung\\ cancer\\,\\ lymphoma\\,\\ and\\ other\\ hypervascular\\ lesions\\ a\\ possibility\\.\ \(0\)\
\-\ 73\\ yo\\ man\\ with\\ copd\\ and\\ chronic\\ back\\ pain\\ from\\ degenerative\\ disc\\ disease\\ and\\ spinal\\ stenosis\\.\\ he\\ presents\\ today\\ with\\ shortness\\ of\\ breath\\ to\\ the\\ er\\.\\ \\ cxr\\ and\\ chest\\ ct\\ were\\ performed\\ during\\ the\\ workup\\ and\\ are\\ shown\\ in\\ figures\\ 1\\ and\\ 2\\.\\ \\ comparison\\ chest\\ cts\\ \\(not\\ shown\\)\\ revealed\\ only\\ mild\\ progression\\ of\\ the\\ findings\\ over\\ the\\ past\\ 5\\ years\\.\ \(0\)\
\-\ pmh\\ is\\ significant\\:\\ more\\ than\\ a\\ decade\\ earlier\\,\\ a\\ routine\\ cxr\\ showed\\ multiple\\ pulmonary\\ nodules\\ and\\ a\\ mediastinal\\ mass\\ was\\ evaluated\\ by\\ ct\\.\\ \\ gallium\\ scan\\ at\\ that\\ time\\ was\\ positive\\.\\ \\ nine\\ years\\ prior\\,\\ he\\ presented\\ with\\ worsening\\ back\\ pain\\ and\\ was\\ found\\ to\\ have\\ an\\ osteolytic\\ lesion\\ at\\ the\\ l3\\ vertebral\\ body\\.\\ \\ biopsy\\ was\\ performed\\ identifying\\ the\\ diagnosis\\.\ \(0\)\
\-\ paraganglioma\\ is\\ uncommon\\,\\ and\\ metastatic\\ paraganglioma\\ is\\ rare\\.\\ \\ most\\ primary\\ lesions\\ are\\ in\\ the\\ head\\+neck\\,\\ adrenal\\ gland\\,\\ or\\ paraspinal\\.\\ \\ these\\ hypervascular\\ tumors\\ are\\ usually\\ slow\\ growing\\ and\\ usually\\ non\\-malignant\\,\\ but\\ treatment\\ is\\ needed\\ as\\ the\\ 5\\-year\\ survival\\ can\\ drop\\ to\\ 20\\%\\.\\ \\ in\\ the\\ past\\,\\ surgical\\ resection\\ \\(perhaps\\ with\\ prior\\ embolization\\ by\\ ir\\)\\ was\\ the\\ definitive\\ treatment\\,\\ but\\ recent\\ treatment\\ has\\ focused\\ on\\ radiotherapy\\.\\ \\ 5\\-year\\ survival\\ rates\\ with\\ treatment\\ can\\ be\\ above\\ 75\\%\\.\\ \\ in\\ the\\ setting\\ of\\ widespread\\ metastatic\\ disease\\,\\ 5\\-year\\ survival\\ rates\\ may\\ drop\\ to\\ 36\\%\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ lee\\ ky\\ et\\.\\ al\\.\\ \\ extraadrenal\\ paragangliomas\\ of\\ the\\ body\\:\\ imaging\\ features\\.\\ \\ ajr\\ 2006\\;\\ 187\\:\\ 492\\-504\\.\ \(0\)\
\-\ trombetta\\ m\\ et\\.\\ al\\.\\ \\ paraganglioma\\:\\ a\\ potentially\\ challenging\\ tumor\\.\\ \\ oncology\\ 2008\\;\\ 22\\(3\\)\\ \\-\\ online\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ paraganglioma\\:\\ 0\\.05165193261084313\ \(0\)\
\-\ hypervascular\\:\\ 0\\.04935857722922789\ \(0\)\
\-\ 5\\-year\\:\\ 0\\.036624428124052505\ \(0\)\
\-\ head\\+neck\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ metastatic\\:\\ 0\\.029409698877563735\ \(0\)\
\-\ survival\\:\\ 0\\.026844210465054134\ \(0\)\
\-\ adrenal\\:\\ 0\\.025352824536529445\ \(0\)\
\-\ partially\\:\\ 0\\.022911583860516026\ \(0\)\
\-\ cxr\\:\\ 0\\.0211290953386235\ \(0\)\
\-\ drop\\:\\ 0\\.02054754047842611\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.02033047074735263\ \(0\)\
\-\ chest\\:\\ 0\\.019968056641186706\ \(0\)\
\-\ potentially\\:\\ 0\\.019565843492953823\ \(0\)\
\-\ rates\\:\\ 0\\.01939597977443922\ \(0\)\
\-\ tumors\\:\\ 0\\.01880693178322559\ \(0\)\
\-\ but\\:\\ 0\\.01779788379915564\ \(0\)\
\-\ ky\\:\\ 0\\.017217809421809567\ \(0\)\
\-\ extraadrenal\\:\\ 0\\.017217809421809567\ \(0\)\
\-\ 187\\:\\ 0\\.017217809421809567\ \(0\)\
\-\ 492\\-504\\.\\:\\ 0\\.017217809421809567\ \(0\)\
\-\ trombetta\\:\\ 0\\.017217809421809567\ \(0\)\
\-\ progression\\:\\ 0\\.0166061337206979\ \(0\)\
\-\ revealed\\:\\ 0\\.016069182948434138\ \(0\)\
\-\ extra\\-adrenal\\:\\ 0\\.015864006334778424\ \(0\)\
\-\ disc\\:\\ 0\\.015543892644589923\ \(0\)\
\-\ degenerative\\:\\ 0\\.015132328130301539\ \(0\)\
\-\ non\\-malignant\\:\\ 0\\.015072082295504665\ \(0\)\
\-\ \\,\\:\\ 0\\.014804456707976654\ \(0\)\
\-\ gallium\\:\\ 0\\.01451020324774728\ \(0\)\
\-\ mediastinal\\:\\ 0\\.014172393039553683\ \(0\)\
\-\ al\\:\\ 0\\.01415063114482925\ \(0\)\
\-\ nodules\\:\\ 0\\.013837964317979498\ \(0\)\
\-\ paragangliomas\\:\\ 0\\.013718279208473521\ \(0\)\
\-\ et\\:\\ 0\\.013661712617665163\ \(0\)\
\-\ lesion\\:\\ 0\\.013598087703128552\ \(0\)\
\-\ treatment\\:\\ 0\\.01351263249688193\ \(0\)\
\-\ was\\:\\ 0\\.01351160674901525\ \(0\)\
\-\ unrevealing\\:\\ 0\\.013417203661935908\ \(0\)\
\-\ hypovascular\\:\\ 0\\.013417203661935908\ \(0\)\
\-\ lesions\\:\\ 0\\.01340367484185907\ \(0\)\
\-\ shown\\:\\ 0\\.013384557399023427\ \(0\)\
\-\ online\\:\\ 0\\.013156400160716137\ \(0\)\
\-\ worsening\\:\\ 0\\.013142499884378116\ \(0\)\
\-\ reveals\\:\\ 0\\.013059561524589935\ \(0\)\
\-\ prior\\:\\ 0\\.012856129524623224\ \(0\)\
\-\ neuroendocrine\\:\\ 0\\.012720572912055571\ \(0\)\
\-\ simulating\\:\\ 0\\.012720572912055571\ \(0\)\
\-\ challenging\\:\\ 0\\.012720572912055571\ \(0\)\
\-\ has\\:\\ 0\\.012536718519486546\ \(0\)\
\-\ encasing\\:\\ 0\\.01253442021712525\ \(0\)\
\-\ breath\\:\\ 0\\.012480927961911517\ \(0\)\
\-\ abnormalities\\:\\ 0\\.012260799303508658\ \(0\)\
\-\ sarcomas\\:\\ 0\\.012208142708017502\ \(0\)\
\-\ lee\\:\\ 0\\.012208142708017502\ \(0\)\
\-\ cts\\:\\ 0\\.012063400574904765\ \(0\)\
\-\ expiratory\\:\\ 0\\.011928648872781812\ \(0\)\
\-\ hormonal\\:\\ 0\\.011928648872781812\ \(0\)\
\-\ laryngeal\\:\\ 0\\.011928648872781812\ \(0\)\
\-\ multilevel\\:\\ 0\\.011802597073684994\ \(0\)\
\-\ figures\\:\\ 0\\.011802597073684994\ \(0\)\
\-\ ir\\:\\ 0\\.011802597073684994\ \(0\)\
\-\ collaterals\\:\\ 0\\.01168418960919977\ \(0\)\
\-\ \\%\\:\\ 0\\.011679615429761763\ \(0\)\
\-\ being\\:\\ 0\\.011631984284377181\ \(0\)\
\-\ mass\\:\\ 0\\.01160606452097231\ \(0\)\
\-\ nine\\:\\ 0\\.011466952040625113\ \(0\)\
\-\ biopsied\\:\\ 0\\.011366769825024428\ \(0\)\
\-\ angiosarcoma\\:\\ 0\\.011366769825024428\ \(0\)\
\-\ thrombosed\\:\\ 0\\.011366769825024428\ \(0\)\
\-\ focused\\:\\ 0\\.011366769825024428\ \(0\)\
\-\ sound\\:\\ 0\\.011271476535631006\ \(0\)\
\-\ rcc\\:\\ 0\\.011271476535631006\ \(0\)\
\-\ osteolytic\\:\\ 0\\.011271476535631006\ \(0\)\
\-\ widespread\\:\\ 0\\.011180617130094106\ \(0\)\
\-\ chem\\:\\ 0\\.011093797281322947\ \(0\)\
\-\ \\:\\:\\ 0\\.011037839999908839\ \(0\)\
\-\ back\\:\\ 0\\.011011977872451083\ \(0\)\
\-\ hcc\\:\\ 0\\.011010673034411235\ \(0\)\
\-\ vascular\\:\\ 0\\.01094454401532694\ \(0\)\
\-\ today\\:\\ 0\\.010930942576363862\ \(0\)\
\-\ perhaps\\:\\ 0\\.010930942576363862\ \(0\)\
\-\ body\\:\\ 0\\.010840873877691736\ \(0\)\
\-\ \\-\\:\\ 0\\.010732783937744317\ \(0\)\
\-\ svc\\:\\ 0\\.010709597487873621\ \(0\)\
\-\ ajr\\:\\ 0\\.010641059753867234\ \(0\)\
\-\ oncology\\:\\ 0\\.010641059753867234\ \(0\)\
\-\ past\\:\\ 0\\.010606247937290758\ \(0\)\
\-\ found\\:\\ 0\\.010519631306453564\ \(0\)\
\-\ identifying\\:\\ 0\\.01044879398665385\ \(0\)\
\-\ 73\\:\\ 0\\.010273770239213055\ \(0\)\
\-\ ventilation\\:\\ 0\\.010165235373676315\ \(0\)\
\-\ usually\\:\\ 0\\.010136438491667028\ \(0\)\
\-\ copd\\:\\ 0\\.010012966737993284\ \(0\)\
\-\ l3\\:\\ 0\\.010012966737993284\ \(0\)\
\-\ original\\:\\ 0\\.009964738979027716\ \(0\)\
\-\ \\(\\:\\ 0\\.00987603922599028\ \(0\)\
\-\ decade\\:\\ 0\\.009826814043062963\ \(0\)\
\-\ years\\:\\ 0\\.009801731003978447\ \(0\)\
\-\ \\)\\:\\ 0\\.009755398134361593\ \(0\)\
\-\ pulmonary\\:\\ 0\\.009752149649297123\ \(0\)\
\-\ wheezing\\:\\ 0\\.009656869947380093\ \(0\)\
\-\ 2008\\:\\ 0\\.009656869947380093\ \(0\)\
\-\ 2006\\:\\ 0\\.009616597902062249\ \(0\)\
\-\ presumed\\:\\ 0\\.00946333302815308\ \(0\)\
\-\ periphery\\:\\ 0\\.009321224914320211\ \(0\)\
\-\ he\\:\\ 0\\.009313231804816482\ \(0\)\
\-\ performed\\:\\ 0\\.009306946606356715\ \(0\)\
\-\ making\\:\\ 0\\.009253869101681208\ \(0\)\
\-\ compatible\\:\\ 0\\.009221042698719527\ \(0\)\
\-\ growing\\:\\ 0\\.009221042698719527\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.009181724716382155\ \(0\)\
\-\ are\\:\\ 0\\.009100577129137514\ \(0\)\
\-\ been\\:\\ 0\\.009081230036968715\ \(0\)\
\-\ slow\\:\\ 0\\.009034890003789204\ \(0\)\
\-\ assessment\\:\\ 0\\.008976583435137483\ \(0\)\
\-\ paraspinal\\:\\ 0\\.008919967152181912\ \(0\)\
\-\ trachea\\:\\ 0\\.008864945908106334\ \(0\)\
\-\ is\\:\\ 0\\.008785793412261338\ \(0\)\
\-\ comparison\\:\\ 0\\.008683731584959916\ \(0\)\
\-\ m\\:\\ 0\\.008610935891996572\ \(0\)\
\-\ workup\\:\\ 0\\.008587261359706836\ \(0\)\
\-\ 75\\:\\ 0\\.008540756186476917\ \(0\)\
\-\ melanoma\\:\\ 0\\.008517912358814434\ \(0\)\
\-\ neoplasms\\:\\ 0\\.008495332627562333\ \(0\)\
\-\ possibility\\:\\ 0\\.008429118659445768\ \(0\)\
\-\ setting\\:\\ 0\\.008429118659445768\ \(0\)\
\-\ 36\\:\\ 0\\.008365076036744613\ \(0\)\
\-\ concern\\:\\ 0\\.00830306686034895\ \(0\)\
\-\ pmh\\:\\ 0\\.00830306686034895\ \(0\)\
\-\ earlier\\:\\ 0\\.008242965964515446\ \(0\)\
\-\ definitive\\:\\ 0\\.008242965964515446\ \(0\)\
\-\ discovered\\:\\ 0\\.008223336402301575\ \(0\)\
\-\ center\\:\\ 0\\.008184659395863724\ \(0\)\
\-\ disease\\:\\ 0\\.008184009030560766\ \(0\)\
\-\ uncommon\\:\\ 0\\.00816560436667356\ \(0\)\
\-\ improved\\:\\ 0\\.007950363858600094\ \(0\)\
\-\ \\;\\:\\ 0\\.007911801517392944\ \(0\)\
\-\ nature\\:\\ 0\\.007900066014650065\ \(0\)\
\-\ imaging\\:\\ 0\\.007820600876779698\ \(0\)\
\-\ recently\\:\\ 0\\.00778750915364101\ \(0\)\
\-\ tumor\\:\\ 0\\.007782157428167231\ \(0\)\
\-\ embolization\\:\\ 0\\.007771946322294962\ \(0\)\
\-\ be\\:\\ 0\\.007721230800843335\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.007666346280751454\ \(0\)\
\-\ evaluated\\:\\ 0\\.007651716062530443\ \(0\)\
\-\ were\\:\\ 0\\.007579243502695005\ \(0\)\
\-\ can\\:\\ 0\\.007571181064332303\ \(0\)\
\-\ poor\\:\\ 0\\.007511142821075191\ \(0\)\
\-\ cbc\\:\\ 0\\.00745762919961403\ \(0\)\
\-\ hemangioma\\:\\ 0\\.00745762919961403\ \(0\)\
\-\ 22\\:\\ 0\\.007444476793009842\ \(0\)\
\-\ may\\:\\ 0\\.007321595191008296\ \(0\)\
\-\ needed\\:\\ 0\\.007269078560858859\ \(0\)\
\-\ bleeding\\:\\ 0\\.007245259668097495\ \(0\)\
\-\ not\\:\\ 0\\.007235265654737902\ \(0\)\
\-\ have\\:\\ 0\\.00722827374361364\ \(0\)\
\-\ calcified\\:\\ 0\\.007164109271783291\ \(0\)\
\-\ gland\\:\\ 0\\.007108141975376307\ \(0\)\
\-\ findings\\:\\ 0\\.00710483178042953\ \(0\)\
\-\ site\\:\\ 0\\.007053733861112701\ \(0\)\
\-\ features\\:\\ 0\\.007043031779541167\ \(0\)\
\-\ multiple\\:\\ 0\\.007030492201090894\ \(0\)\
\-\ shortness\\:\\ 0\\.007021801950953464\ \(0\)\
\-\ ct\\:\\ 0\\.007003732344094002\ \(0\)\
\-\ references\\:\\ 0\\.006939117646604712\ \(0\)\
\-\ thyroid\\:\\ 0\\.006840453993993576\ \(0\)\
\-\ considered\\:\\ 0\\.006737387517470013\ \(0\)\
\-\ routine\\:\\ 0\\.006692278699511714\ \(0\)\
\-\ vertebral\\:\\ 0\\.006605071133617692\ \(0\)\
\-\ aneurysm\\:\\ 0\\.006596560771568951\ \(0\)\
\-\ also\\:\\ 0\\.006580545287774029\ \(0\)\
\-\ stenosis\\:\\ 0\\.006538004458655013\ \(0\)\
\-\ rare\\:\\ 0\\.006481152731783782\ \(0\)\
\-\ er\\:\\ 0\\.006402703431538988\ \(0\)\
\-\ its\\:\\ 0\\.0062979129754992995\ \(0\)\
\-\ confirmed\\:\\ 0\\.006276171099778901\ \(0\)\
\-\ a\\:\\ 0\\.006196871903415645\ \(0\)\
\-\ breast\\:\\ 0\\.006157339734044047\ \(0\)\
\-\ laboratory\\:\\ 0\\.006150569796589973\ \(0\)\
\-\ above\\:\\ 0\\.006117067688726204\ \(0\)\
\-\ middle\\:\\ 0\\.006103826112582886\ \(0\)\
\-\ they\\:\\ 0\\.00601356665329552\ \(0\)\
\-\ 20\\:\\ 0\\.0060010063206191715\ \(0\)\
\-\ spinal\\:\\ 0\\.005976125410897629\ \(0\)\
\-\ biopsy\\:\\ 0\\.005921275862571798\ \(0\)\
\-\ to\\:\\ 0\\.0058388217951189526\ \(0\)\
\-\ labs\\:\\ 0\\.005804636732295192\ \(0\)\
\-\ that\\:\\ 0\\.005765549720932904\ \(0\)\
\-\ recent\\:\\ 0\\.005610779392265229\ \(0\)\
\-\ by\\:\\ 0\\.005558089465800292\ \(0\)\
\-\ spine\\:\\ 0\\.005496295988291695\ \(0\)\
\-\ cancer\\:\\ 0\\.005486650906962432\ \(0\)\
\-\ radiation\\:\\ 0\\.005477053221801438\ \(0\)\
\-\ showed\\:\\ 0\\.00547227200766347\ \(0\)\
\-\ positive\\:\\ 0\\.0054157921685236655\ \(0\)\
\-\ the\\:\\ 0\\.005400362683735383\ \(0\)\
\-\ 2\\.\\:\\ 0\\.005307508089453629\ \(0\)\
\-\ resection\\:\\ 0\\.005204913389687927\ \(0\)\
\-\ during\\:\\ 0\\.0051074399412574375\ \(0\)\
\-\ yo\\:\\ 0\\.005022170943950707\ \(0\)\
\-\ only\\:\\ 0\\.00501838214547839\ \(0\)\
\-\ decreased\\:\\ 0\\.004962414849071405\ \(0\)\
\-\ from\\:\\ 0\\.004947014504508642\ \(0\)\
\-\ primary\\:\\ 0\\.004944109888468157\ \(0\)\
\-\ in\\:\\ 0\\.004938248790706113\ \(0\)\
\-\ 5\\:\\ 0\\.004883125825086257\ \(0\)\
\-\ lung\\:\\ 0\\.004834295156716301\ \(0\)\
\-\ syndrome\\:\\ 0\\.004773255032684847\ \(0\)\
\-\ lymphoma\\:\\ 0\\.004769919207791964\ \(0\)\
\-\ time\\:\\ 0\\.004714064896951782\ \(0\)\
\-\ chronic\\:\\ 0\\.004701151626771484\ \(0\)\
\-\ scan\\:\\ 0\\.004672405196158161\ \(0\)\
\-\ presented\\:\\ 0\\.004549526630903143\ \(0\)\
\-\ at\\:\\ 0\\.004522512315748566\ \(0\)\
\-\ significant\\:\\ 0\\.00448798271690278\ \(0\)\
\-\ due\\:\\ 0\\.004453666314361015\ \(0\)\
\-\ mild\\:\\ 0\\.004395026277209252\ \(0\)\
\-\ than\\:\\ 0\\.004373142294762254\ \(0\)\
\-\ these\\:\\ 0\\.004343446663980156\ \(0\)\
\-\ over\\:\\ 0\\.004249301933867114\ \(0\)\
\-\ and\\:\\ 0\\.00421896107184887\ \(0\)\
\-\ more\\:\\ 0\\.004174172479125325\ \(0\)\
\-\ physical\\:\\ 0\\.004094736854650856\ \(0\)\
\-\ pain\\:\\ 0\\.0040765944044169325\ \(0\)\
\-\ 1\\:\\ 0\\.0039713405624213025\ \(0\)\
\-\ man\\:\\ 0\\.003947132506035155\ \(0\)\
\-\ 3\\:\\ 0\\.00390815532559871\ \(0\)\
\-\ most\\:\\ 0\\.0038531936361876486\ \(0\)\
\-\ other\\:\\ 0\\.00384695029043447\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0038324596304305076\ \(0\)\
\-\ exam\\:\\ 0\\.0036664725389639417\ \(0\)\
\-\ large\\:\\ 0\\.0036494969371700776\ \(0\)\
\-\ had\\:\\ 0\\.0036012691782045083\ \(0\)\
\-\ surgical\\:\\ 0\\.0035082456450223703\ \(0\)\
\-\ presents\\:\\ 0\\.0034094615146639177\ \(0\)\
\-\ no\\:\\ 0\\.0033611099636867265\ \(0\)\
\-\ which\\:\\ 0\\.003115516771958103\ \(0\)\
\-\ as\\:\\ 0\\.0025245654411994683\ \(0\)\
\-\ there\\:\\ 0\\.002483819446220681\ \(0\)\
\-\ an\\:\\ 0\\.002307939188056113\ \(0\)\
\-\ \\.\\:\\ 0\\.0022880560375242716\ \(0\)\
\-\ or\\:\\ 0\\.0019560991190697413\ \(0\)\
\-\ this\\:\\ 0\\.001877221119754166\ \(0\)\
\-\ with\\:\\ 0\\.0018281902514045271\ \(0\)\
\-\ patient\\:\\ 0\\.0016730311150710702\ \(0\)\
\-\ of\\:\\ 0\\.0015928254015349981\ \(0\)\
\-\ for\\:\\ 0\\.001424039352817803\ \(0\)\
\-\ on\\:\\ 0\\.0014138496335262267\ \(0\)\
